Congregation Kerem Shalom hosted this symposium in partnership with Hadassah to educate the community about Ashkenazi Jews’ one-in-forty risk of inheriting a BRCA gene mutation.
Thursday, November 9, 2017
Congregation Kerem Shalom
Concord, MA
Congregation Kerem Shalom hosted this symposium in partnership with Hadassah to educate the community about Ashkenazi Jews’ one-in-forty risk of inheriting a BRCA gene mutation. People who have a BRCA mutation are at relatively high risk for developing ovarian, prostate and male and female breast cancer.
Attendees learned about genetic counseling, screening for BRCA mutations, misconceptions about hereditary cancer, how BRCA-positive individuals can manage their risk of developing cancer, emotional support resources available for them and their families and the new BRCA Founder Outreach Study being conducted by Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Following presentations by each of the panelists listed below, there was a Q&A session.
Lauren Corduck, In Memoriam January 31, 1971 – December 24, 2020
Founder
Oneinforty
Camila Gabriel, MS
Senior Research Project Manager
Center for Cancer Genetics and Prevention
Dana-Farber Cancer Institute
Whitfield B. Growdon, MD
Center for Gynecologic Oncology
Massachusetts General Hospital
Meredith Seidel, MS, LCGC
Manager, Cancer Center Genetics Program
Center for Cancer Risk Assessment
Massachusetts General Hospital
Marcia Lewin-Berlin, LICSW, ACHP-SW
Co-Director of Wellness and Integrative Care
The Virginia Thurston Healing Garden